Balyasny Asset Management
OCGN icon

Balyasny Asset Management’s Ocugen OCGN Stock Holding History

Balyasny Asset Management’s Portfolio OCGN Stock Details OCGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-145,435
Closed -$196K – 3336
2025
Q4 		$196K Buy
+145,435
New +$207K ﹤0.01% 2889
2024
Q2 		– Sell
-110,836
Closed -$182K – 2956
2024
Q1 		$182K Buy
+110,836
New +$92.9K ﹤0.01% 2429
2023
Q4 		– Sell
-12,407
Closed -$4.96K – 2781
2023
Q3 		$4.96K Sell
12,407
-30,071
-71% -$14.8K ﹤0.01% 2189
2023
Q2 		$23.1K Buy
+42,478
New +$27.2K ﹤0.01% 2154
2023
Q1 		– Sell
-81,055
Closed -$105K – 3004
2022
Q4 		$105K Buy
81,055
+12,818
+19% +$20K ﹤0.01% 2244
2022
Q3 		$121K Buy
68,237
+26,985
+65% +$67.2K ﹤0.01% 2388
2022
Q2 		$94K Buy
+41,252
New +$98.7K ﹤0.01% 2287

Other funds holding OCGN

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Balyasny Asset Management's OCGN Position: Q1 2026 in Review

Balyasny Asset Management sold out of Ocugen (OCGN) in Q1 2026, closing a stake of 145,435 shares — an estimated $196K sold.

Balyasny Asset Management first reported a position in OCGN in Q2 2022 and held it in 7 quarters. The position peaked at $196K in Q4 2025. 137 funds tracked by Wall St. Rank hold OCGN as of Q1 2026.

  • Balyasny Asset Management reported no remaining Ocugen position as of Q1 2026 after selling out during the quarter.
  • Balyasny Asset Management sold 145,435 Ocugen shares in Q1 2026, an estimated $196K.
  • Balyasny Asset Management first reported a position in Ocugen in Q2 2022 and held it in 7 quarters.
  • Balyasny Asset Management's Ocugen position peaked at $196K in Q4 2025.
  • 137 funds tracked by Wall St. Rank held Ocugen as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.